The Journal of Nanotheranostics: A New Open-Access Journal at the Interface of Nanotechnology, Materials Science, and Medicine for Precision Medicine
Conflicts of Interest
Short Biography of Author
|Moein Moghimi is a Professor of Pharmaceutics and Nanomedicine (School of Pharmacy) and Research Professor (Translational and Clinical Research Institute) at Newcastle University (UK); Adjoint Professor at the Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado-Denver Medical Center (USA); and Associate Editor of Molecular Therapy (Cell Press). His earlier appointments have included Professor and Chair in Pharmaceutics at the School of Medicine, Pharmacy and Health, Durham University, UK (2016–2017); Full Affiliate Member/Professor at the Methodist Research Institute, Houston Methodist Hospital Systems, Houston, Texas, USA (2013–2017); Visiting Professor at Università Degli Studi Di Padova, Padova, Italy (2015); Professor of Nanomedicine (at the Department of Pharmacy), Professor of Pharmaceutical Nanotechology (at the NanoScience Center); and Founder/Director of the Center for Pharmaceutical Nanotechnology and Nanotoxiocology, University of Copenhagen, Denmark (2008–2016); and Honorary Professor of Nanomedicine at the Multidisciplinary Research Center, Shantou University, China (2008–2010).|
Prof. Moghimi’s research is centered on fundamental and translational aspects of nanomedicine engineering and performance, with the overall goal of advancing fundamental understanding of biological barriers in relation to nanoparticle performance and safety, and within the context of precision medicine applicable to cancer, cardiovascular diseases, immune disorders, and disease of the central nervous system. To date, Prof. Moghimi has published >300 research papers, reviews, book chapters, proceedings, and patents/patent applications, and his work is highly cited in scientific literature. He is widely reported in general, local, and professional press and serves on the editorial boards of >10 international journals including Advanced Drug Delivery Reviews, Journal of Controlled Release, and Nanomedicine (UK).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
© 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Moghimi, S.M. The Journal of Nanotheranostics: A New Open-Access Journal at the Interface of Nanotechnology, Materials Science, and Medicine for Precision Medicine. J. Nanotheranostics 2020, 1, 56-57. https://doi.org/10.3390/jnt1010005
Moghimi SM. The Journal of Nanotheranostics: A New Open-Access Journal at the Interface of Nanotechnology, Materials Science, and Medicine for Precision Medicine. Journal of Nanotheranostics. 2020; 1(1):56-57. https://doi.org/10.3390/jnt1010005Chicago/Turabian Style
Moghimi, S. Moein. 2020. "The Journal of Nanotheranostics: A New Open-Access Journal at the Interface of Nanotechnology, Materials Science, and Medicine for Precision Medicine" Journal of Nanotheranostics 1, no. 1: 56-57. https://doi.org/10.3390/jnt1010005